XML 35 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurement
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurement 4. Fair Value Measurement
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the
fair value hierarchy levels disclosed in Note 2 as of December 31, 2023:
Level I
Level II
Level III
Total
Assets
(Dollars in millions)
Investments of Consolidated Funds(1):
Equity securities(2)
$
$
$377.6
$377.6
Bonds
522.5
522.5
Loans
5,862.1
5,862.1
6,762.2
6,762.2
Investments in CLOs and other:
Investments in CLOs
532.6
532.6
Other investments(3)
38.7
42.8
84.6
166.1
38.7
42.8
617.2
698.7
Subtotal
$38.7
$42.8
$7,379.4
$7,460.9
Investments measured at net asset value
502.0
Total
$7,962.9
Liabilities
Loans payable of Consolidated Funds(4)(5)
$
$
$6,298.6
$6,298.6
Total
$
$
$6,298.6
$6,298.6
(1)This balance excludes $490.9 million related to investments of Consolidated Funds that are included in investments measured at net
asset value.
(2)This balance includes $322.0 million related to investments that have been bridged by the Company to investment funds and are
accounted for as consolidated VIEs as of December 31, 2023.
(3)The Level III balance excludes $50.4 million related to three corporate investments in equity securities which the Company has
elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to
ASC 321, Investments – Equity Securities. As a non-recurring fair value measurement, the fair value of these equity securities is
excluded from the tabular Level III rollforward disclosures.
(4)Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial
assets, less (i) the fair value of any beneficial interest held by the Company and (ii) the carrying value of any beneficial interests that
represent compensation for services.
(5)Loans payable of Consolidated Funds balance excludes a $177.9 million revolving credit balance and $10.0 million of senior and
subordinated notes, which are not measured at fair value.
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the
above fair value hierarchy levels as of December 31, 2022:
(Dollars in millions)
Level I
Level II
Level III
Total
Assets
(Dollars in millions)
Investments of Consolidated Funds(1):
Equity securities(2)
$
$
$430.6
$430.6
Bonds
594.9
594.9
Loans
5,352.9
5,352.9
6,378.4
6,378.4
Investments in CLOs and other:
Investments in CLOs
526.1
526.1
Other investments(3)
1.6
41.6
79.4
122.6
1.6
41.6
605.5
648.7
Corporate treasury investments
Commercial paper and other
20.0
20.0
20.0
20.0
Foreign currency forward contracts
2.2
2.2
Subtotal
$1.6
$63.8
$6,983.9
$7,049.3
Investments measured at net asset value
528.5
Total
$7,577.8
Liabilities
Loans payable of Consolidated Funds(4)
$
$
$5,491.6
$5,491.6
Foreign currency forward contracts
3.2
3.2
Total
$
$3.2
$5,491.6
$5,494.8
(1)This balance includes $377.4 million related to investments that have been bridged by the Company to investment funds and are
accounted for as consolidated VIEs as of December 31, 2022.
(2)The Level III balance excludes a $58.2 million related to two corporate investments in equity securities which the Company has
elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to
ASC 321, Investments – Equity Securities. As a non-recurring fair value measurement, the fair value of these equity securities is
excluded from the tabular Level III rollforward disclosures.
(3)Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial
assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests
that represent compensation for services.
(4) Loans payable of Consolidated Funds balance excludes a $235.6 million of senior notes measured at amortized cost and a
$178.0 million revolving credit balance, which is not measured at fair value.
The changes in financial instruments measured at fair value for which the Company has used Level III inputs to
determine fair value are as follows (Dollars in millions):
 
Financial Assets Year Ended December 31, 2023
Investments of Consolidated Funds
Investments
in CLOs
Total
Equity
securities
Bonds
Loans
Other
investments
Balance, beginning of period
$430.6
$594.9
$5,352.9
$526.1
$79.4
$6,983.9
Deconsolidation of funds(1)
(20.0)
(429.5)
(449.5)
Purchases
85.8
168.9
2,549.5
2.0
2,806.2
Sales and distributions
(104.5)
(269.0)
(1,151.2)
(58.0)
(3.5)
(1,586.2)
Settlements
(8.2)
(740.4)
(748.6)
Realized and unrealized gains (losses), net
Included in earnings
(14.4)
21.0
182.7
43.4
8.7
241.4
Included in other comprehensive income
0.1
14.9
98.1
19.1
132.2
Balance, end of period
$377.6
$522.5
$5,862.1
$532.6
$84.6
$7,379.4
Changes in unrealized gains (losses) included in
earnings related to financial assets still held at the
reporting date
$(15.7)
$13.8
$131.5
$43.3
$5.2
$178.1
Changes in unrealized gains (losses) included in
other comprehensive income related to financial
assets still held at the reporting date
$0.1
$12.4
$93.4
$19.1
$
$125.0
 
Financial Assets Year Ended December 31, 2022
 
Investments of Consolidated Funds
Investments
in CLOs
Total
 
Equity
securities
Bonds
Loans
Other
investments
Balance, beginning of period
$17.9
$599.5
$5,898.1
$361.1
$78.7
$6,955.3
Deconsolidation of funds(2)
(47.7)
(47.7)
Purchases
486.5
515.4
2,485.0
263.4
0.9
3,751.2
Sales and distributions
(14.5)
(419.6)
(1,738.7)
(41.9)
(4.7)
(2,219.4)
Settlements
(1.6)
(649.8)
(651.4)
Realized and unrealized gains (losses), net
Included in earnings
(10.9)
(60.5)
(392.7)
(25.6)
4.5
(485.2)
Included in other comprehensive income
(0.7)
(38.3)
(249.0)
(30.9)
(318.9)
Balance, end of period
$430.6
$594.9
$5,352.9
$526.1
$79.4
$6,983.9
Changes in unrealized gains (losses) included in
earnings related to financial assets still held at the
reporting date
$(16.4)
$(56.9)
$(380.6)
$(25.6)
$1.0
$(478.5)
Changes in unrealized gains (losses) included in
other comprehensive income related to financial
assets still held at the reporting date
$(0.6)
$(16.5)
$(162.5)
$(30.9)
$
$(210.5)
 
(1) As a result of the deconsolidation of three funds during the year ended December 31, 2023.
(2) As a result of the deconsolidation of one fund during the year ended December 31, 2022.
 
Financial Liabilities
Loans Payable of Consolidated Funds
Year Ended December 31,
 
2023
2022
Balance, beginning of period
$5,491.6
$5,811.0
Borrowings
903.0
1,603.1
Paydowns
(159.6)
(421.0)
Sales
(290.8)
(892.4)
Realized and unrealized (gains) losses, net
Included in earnings
239.7
(366.6)
Included in other comprehensive income
114.7
(242.5)
Balance, end of period
$6,298.6
$5,491.6
Changes in unrealized (gains) losses included in earnings related to
financial liabilities still held at the reporting date
$250.1
$(364.2)
Changes in unrealized (gains) losses included in other comprehensive
income related to financial liabilities still held at the reporting date
$112.4
$(239.6)
 
Realized and unrealized gains and losses included in earnings for Level III investments for investments in CLOs and
other investments are included in investment income (loss), and such gains and losses for investments of Consolidated Funds
and loans payable of the Consolidated Funds are included in net investment gains (losses) of Consolidated Funds in the
consolidated statements of operations.
Gains and losses included in other comprehensive income for all Level III financial asset and liabilities are included in
accumulated other comprehensive loss and non-controlling interests in consolidated entities.
 
The following table summarizes quantitative information about the Company’s Level III inputs as of December 31,
2023:
Fair Value at
Range
(Weighted
Average)
(Dollars in millions)
December 31, 2023
Valuation Technique(s)
Unobservable Input(s)
Assets
Investments of Consolidated Funds:
Equity securities
$3.3
Consensus Pricing
Indicative Quotes ($ per share)
0.00 - 208.38 (0.11)
322.1
Discounted Cash Flow
Discount Rates
10% - 11% (10%)
Terminal Growth Rate
0% - 7% (5%)
Comparable Multiple
EBITDA Multiple
12.7x - 12.7x (12.7x)
TCF Multiple
24.3x - 24.3x (24.3x)
44.4
Discounted Cash Flow
Discount Rates
10% - 10% (10%)
Terminal Growth Rate
7% - 7% (7%)
Comparable Multiple
TCF Multiple
24.3x - 24.3x (24.3x)
7.8
Other(1)
N/A
N/A
Bonds
522.5
Consensus Pricing
Indicative Quotes (% of Par)
30 - 105 (90)
Loans
5,829.3
Consensus Pricing
Indicative Quotes (% of Par)
0 - 102 (95)
11.0
Discounted Cash Flow
Discount Rates
7% - 16% (15%)
9.4
Discounted Cash Flow
Discount Rates
17% - 17% (17%)
Constant Prepayment Rate
8% - 8% (8%)
Constant Default Rate
1% - 1% (1%)
Recovery Rate
0% - 0% (0%)
12.4
Other(1)
N/A
N/A
6,762.2
Investments in CLOs
Senior secured notes
472.2
Discounted Cash Flow with
Consensus Pricing
Indicative Quotes (% of Par)
72 - 101 (96)
Discount Margins (Basis
Points)
139 - 1,600 (319)
Default Rates
2% - 2% (2%)
Recovery Rates
60% - 60% (60%)
Subordinated notes and preferred
shares
59.4
Discounted Cash Flow with
Consensus Pricing
Indicative Quotes (% of Par)
6 - 90 (40)
Discount Rate
11% - 40% (21%)
Default Rates
1% - 2% (2%)
Recovery Rates
60% - 60% (60%)
1.0
Other(1)
N/A
N/A
Other investments:
BDC preferred shares
81.7
Market Yield Analysis
Market Yields
11% - 11% (11%)
Aviation subordinated notes
2.9
Discounted Cash Flow
Discount Rates
21% - 21% (21%)
Total
$7,379.4
Liabilities
Loans payable of Consolidated Funds:
Senior secured notes
$6,090.1
Other(2)
N/A
N/A
Subordinated notes and preferred
shares
190.0
Discounted Cash Flow with
Consensus Pricing
Indicative Quotes (% of Par)
16 - 103 (41)
Discount Rates
14% - 30% (21%)
Default Rates
2% - 2% (2%)
Recovery Rates
60% - 60% (60%)
18.5
Other(1)
N/A
N/A
Total
$6,298.6
(1)  Fair value approximates transaction price that was in close proximity to the reporting date.
(2)  Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial
assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that
represent compensation for services.
The following table summarizes quantitative information about the Company’s Level III inputs as of December 31,
2022:
Fair Value at
Range
(Weighted
Average)
(Dollars in millions)
December 31, 2022
Valuation Technique(s)
Unobservable Input(s)
Assets
Investments of Consolidated Funds:
Equity securities
$3.1
Consensus Pricing
Indicative Quotes
($ per share)
0.00 - 4.73 (0.18)
363.5
Discounted Cash Flow
Discount Rates
10% - 10% (10%)
Terminal Growth Rate
0% - 7% (5%)
Comparable Multiple
EBITDA Multiple
12.7x - 12.7x (12.7x)
TCF Multiple
23.8x - 23.8x (23.8x)
64.0
Other(1)
N/A
N/A
Bonds
594.9
Consensus Pricing
Indicative Quotes (% of Par)
46 - 105 (88)
Loans
5,043.4
Consensus Pricing
Indicative Quotes (% of Par)
0 - 100 (91)
11.8
Discounted Cash Flow
Discount Rates
0% - 9% (1%)
248.7
Discounted Cash Flow
Discount Rates
7% - 10% (8%)
37.4
Consensus Pricing
Indicative Quotes (% of Par)
97% - 98% (97%)
11.1
Consensus Pricing
Indicative Quotes (% of Par)
91% - 91% (91%)
Other
0.5
Other(1)
N/A
N/A
6,378.4
Investments in CLOs
Senior secured notes
462.1
Discounted Cash Flow with
Consensus Pricing
Indicative Quotes (% of Par)
67 - 100 (93)
Discount Margins (Basis
Points)
170 - 1,800 (386)
Default Rates
2% - 3% (2%)
Recovery Rates
50% - 70% (60%)
Subordinated notes and preferred
shares
64.0
Discounted Cash Flow with
Consensus Pricing
Indicative Quotes (% of Par)
0 - 82 (40)
Discount Rate
15% - 25% (20%)
Default Rates
2% - 3% (2%)
Recovery Rates
50% - 70% (60%)
Other investments:
BDC preferred shares
76.9
Market Yield Analysis
Market Yields
11% - 11% (11%)
Aviation subordinated notes
2.5
Discounted Cash Flow
Discount Rates
21% - 21% (21%)
Total
$6,983.9
Liabilities
Loans payable of Consolidated Funds:
Senior secured notes
$5,303.3
Other(2)
N/A
N/A
Subordinated notes and preferred
shares
188.3
Discounted Cash Flow with
Consensus Pricing
Indicative Quotes (% of Par)
21 - 96 (38)
Discount Rates
15% - 25% (20%)
Default Rates
2% - 3% (3%)
Recovery Rates
50% - 70% (60%)
Total
$5,491.6
 
(1)Fair value approximates transaction price that was in close proximity to the reporting date.
(2)Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial
assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests
that represent compensation for services.
The significant unobservable inputs used in the fair value measurement of investments of the Company’s consolidated
funds are indicative quotes. Significant decreases in indicative quotes in isolation would result in a significantly lower fair value
measurement.
The significant unobservable inputs used in the fair value measurement of the Company’s investments in CLOs and
other investments include indicative quotes, discount margins, discount rates, default rates, and recovery rates. Significant
decreases in indicative quotes or recovery rates in isolation would result in a significantly lower fair value measurement.
Significant increases in discount margins, discount rates or default rates in isolation would result in a significantly lower fair
value measurement.
The significant unobservable inputs used in the fair value measurement of the Company’s loans payable of
Consolidated Funds are discount rates, default rates, recovery rates and indicative quotes. Significant increases in discount rates
or default rates in isolation would result in a significantly lower fair value measurement. Significant decreases in recovery rates
or indicative quotes in isolation would result in a significantly lower fair value measurement.